Blepharoplasty Market: Global Industry Analysis and Forecast (2023 – 2029) Trends, Statistics, Dynamics, Segmentation by Gender, Type, Service Provider, and Region

The Blepharoplasty Market size was valued at USD 4.3 Mn. in 2022 and the total Blepharoplasty revenue is expected to grow by 8.5 % from 2023 to 2029, reaching nearly USD 7.6 Mn.
Blepharoplasty Market Overview:
Blepharoplasty is a surgical procedure performed to correct sagging or drooping eyelids, and the global blepharoplasty market is expected to grow significantly during the forecast period. The market is increasing in demand for cosmetic surgeries, particularly among the aging population. People's skin loses elasticity as they age, and the muscles around their eyes weaken, resulting in sagging or drooping eyelids. Thanks to the increasing number of people who are seeking blepharoplasty to improve the appearance of their eyes and to achieve a more attractive appearance.

The high cost of the procedure makes it unaffordable for some patients. Additionally, some patients are hesitant to undergo surgery because of the associated risks and potential complications. Development of minimally invasive techniques for blepharoplasty which makes the procedure more accessible to a wider range of patients. Key players in the market include Allergan, Merz Pharma, Alma Lasers, Erchonia Corporation, and Cynosure, who are focusing on product development and innovation, strategic partnerships and collaborations, and mergers and acquisitions to grow their product portfolios and increase their market share. These techniques involve using lasers or other non-surgical methods to remove excess skin and fat from the eyelids, reducing the risk of scarring and shortening the recovery time. The development of such techniques makes the blepharoplasty market more accessible to a wider range of patients, increasing demand for the procedure and driving growth in the blepharoplasty market.To know about the Research Methodology :- Request Free Sample Report
Market Dynamics:
Competitive Landscape:

The global blepharoplasty market is highly competitive and includes several key players that specialize in aesthetic medicine, medical devices, and pharmaceuticals. These players include Allergan, Merz Pharma, Johnson & Johnson, Galderma, Zimmer Biomet, Hologic, Valeant Pharmaceuticals International, and Sientra.

Allergan Inc : Allergan is a leading global pharmaceutical company that specializes in developing, manufacturing, and marketing medical aesthetics products, including eyelid surgery products. Johnson & Johnson: Is a multinational corporation that develops and markets a range of healthcare products, including ophthalmic surgery products. Merz Pharma GmbH & Co. KGaA: Merz Pharma is a leading global aesthetics and neurotoxin company that offers a range of products and solutions for blepharoplasty procedures. Galderma SA: Galderma is a Swiss-based company that develops, manufactures, and markets a range of dermatology products, including surgical products for eyelid surgery. And Zimmer Biomet Holdings Inc.: Is a global medical device company that provides a range of products and solutions for ophthalmic surgery, including blepharoplasty procedures.


Blepharoplasty Market Trend
Increasing adoption of non-invasive procedures

The growth is driven by the growing demand for minimally invasive procedures that offer faster recovery times and fewer risks compared to traditional surgical procedures. The development of advanced technologies such as plasma technology and ultrasound-based devices has contributed to the growth of non-invasive blepharoplasty procedures. These technologies offer precise and controlled tissue ablation and tightening, with minimal damage to surrounding tissues. The COVID-19 pandemic has also impacted the blepharoplasty market, with many patients preferring non-invasive procedures that can be done in-office with minimal downtime and fewer risks of exposure to the virus. The trend towards non-invasive blepharoplasty procedures is expected to continue, as more patients seek out less invasive and more convenient options for rejuvenating their appearance, and the market for non-invasive blepharoplasty is projected to grow in the forecast years.

Blepharoplasty Market Drivers

Growing demand for the procedure among the aging population

The growth is driven by factors such as the rising aging population, increased disposable income, and the desire to enhance one's appearance. The American Society of Plastic Surgeons reported that in 2020, blepharoplasty was the fourth most popular cosmetic surgery in the United States, with over 211,000 procedures performed. Moreover, the popularity of the procedure is not limited to the United States, as it is also gaining popularity in countries such as China, Japan, and South Korea. The growing demand for blepharoplasty has also led to the development of new techniques, such as non-invasive procedures and advanced technologies, which have contributed to the growth of the market. The aging population's desire to maintain a youthful appearance is a significant driver of the blepharoplasty market, and this is expected to continue in the forecast years, fueling the market's growth.
Blepharoplasty Market Restraints
High cost of the surgery and the risk of complications associated with the procedure

The average cost of blepharoplasty surgery in the United States is between $2,000 to $7,000, depending on the extent of the procedure and other factors such as the surgeon's experience and location. The high cost of the surgery deters some potential patients from undergoing the procedure, particularly those who do not have adequate health insurance coverage or disposable income. Additionally, there is a risk of complications associated with the surgery, such as infection, bleeding, and scarring, which also deter patients from undergoing the procedure. The COVID-19 pandemic has also had an impact on the blepharoplasty market, with many patients delaying or canceling their surgeries due to safety concerns or financial constraints. The high cost of the surgery and the risk of complications associated with the procedure are significant restraints of the blepharoplasty market.



Blepharoplasty Market Opportunity

Technological advancements such as plasma technology and laser-assisted devices

Increasing adoption of non-invasive procedures, such as radiofrequency and ultrasound-based devices, which offer significant benefits over traditional surgical procedures. The growth is driven by the growing demand for minimally invasive procedures that offer faster recovery times, fewer risks, and lower costs compared to traditional surgical procedures. Non-invasive procedures are also becoming increasingly popular among younger patients who wish to enhance their appearance without undergoing surgery. Moreover, technological advancements such as plasma technology and laser-assisted devices are also driving the growth of the market, offering precise and controlled tissue ablation and tightening with minimal damage to surrounding tissues. The rising adoption of non-invasive procedures presents a significant opportunity for companies operating in the blepharoplasty market, as they develop innovative technologies and techniques that cater to the growing demand for these procedures. The trend toward non-invasive blepharoplasty procedures presents a significant opportunity for companies operating in the market, and this trend is expected to continue in the forecast years.
Blepharoplasty Market Segment Analysis:
Based on Gender, The blepharoplasty market is divided into two gender segments: female and male. The female segment dominated the market in 2021 and is expected to do so again during the forecast period. This is expected to increase the desire to improve one's appearance by revitalizing the appearance of the eyes, making them appear more youthful and refreshed. However, the male segment is expected to experience significant market growth during the forecast period, owing to increased awareness among men to improve their appearance, which increases the demand for blepharoplasty surgery.



Based on the Type, The Upper eyelid surgery segment dominated the global market in 2021 and is expected to continue to do so during the forecast period, owing to the fact that most patients prefer upper eyelid surgery because it provides improved vision, less double vision, and a more youthful appearance. However, the lower eyelid surgery segment is expected to grow significantly during the forecast period, owing to an increase in the geriatric population and an increase in demand for non-invasive surgical procedures that help to reduce excess fat under the eyes, which are the factors driving the market growth. The Upper Eyelid Blepharoplasty segment was the largest segment in the market for blepharoplasty. This procedure involves the removal of excess skin and fat from the upper eyelids, resulting in a more youthful and refreshed appearance. The Lower Eyelid Blepharoplasty segment involves the removal of excess skin and fat from the lower eyelids, while Combination Eyelid Surgery involves both upper and lower eyelid procedures performed simultaneously. The choice of which type of blepharoplasty procedure to perform depends on the patient's individual needs and desired outcomes.



Based on the Service Provider, The market is divided into three segments: hospitals, clinics, and ambulatory surgical centers. The hospital segment dominated the global market in 2021 and is expected to maintain this dominance throughout the forecast period. Thanks to an increase in the number of hospitals offering surgical procedures for eyelids using technologically advanced medical devices, as well as an increase in the number of patients undergoing cosmetical surgeries at hospital facilities. However, the clinic’s segment is expected to grow significantly during the forecast period. This is due to the availability of advanced medical equipment and well-trained healthcare personnel.


Blepharoplasty Market Regional Insights:
North America dominated the blepharoplasty market in the year 2022 and is expected to do the same during the forecast period. Thanks to the high demand for cosmetic procedures in the United States and Canada, as well as the presence of a large number of skilled plastic surgeons. In addition, many insurance plans in North America cover blepharoplasty as a medically necessary procedure for patients with vision impairment caused by sagging eyelids.

The blepharoplasty market in Asia Pacific is growing rapidly, driven by increasing disposable incomes, changing beauty standards, and a growing awareness of the benefits of cosmetic procedures. In particular, South Korea is a major market for blepharoplasty, with many people seeking the "double eyelid" look, which involves creating a crease in the eyelid to make the eyes appear larger.

The blepharoplasty market in Europe is also growing, although at a slower pace than in North America and Asia Pacific. This is due in part to the stricter regulatory environment in Europe, which makes it more difficult for new products and procedures to enter the market. However, there is still strong demand for blepharoplasty in countries like the United Kingdom, France, and Germany.
Blepharoplasty Market Scope: Inquiry Before Buying



Blepharoplasty Market


Report Coverage
Details


Base Year:
2022
Forecast Period:
2023-2029


Historical Data:
2017 to 2022
Market Size in 2022:
USD 4.3 Mn


Forecast Period 2023 to 2029 CAGR:
8.5%
Market Size in 2029:
USD 7.6 Mn


 Segments Covered:
by Gender
1. Female
2.Male


by Type
1. Upper Eyelid Blepharoplasty
2. Lower Eyelid Blepharoplasty
3. Combination Eyelid Surgery


by Service Provider
1. Hospitals
2. Clinics
3. Ambulatory Surgical Centre



Blepharoplasty Market by Region
North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)
Blepharoplasty Market Key Players
1. Allergan
2. Merz Pharma
3. Alma Lasers
4. Johnson & Johnson
5. Galderma
6. Zimmer Biomet
7. Hologic
8. Valeant Pharmaceuticals International
9. Sientra
10. Erchonia Corporation
11. Cynosure
12. Abbvie Inc
13. LightScalpel
14. Lumenis
15. Medtronic plc
16. Surgical Holdings Ltd.
17. Medline industries, inc.
18. Sisram Medical Ltd
19. Grand Aespio Inc.
20. London Bridge Plastic Surgery
21. M A Corporation

Frequently Asked Questions:

1] What segments are covered in the Global BlepharoplastyMarket report?
Ans. The segments covered in the BlepharoplastyMarket report are based on Gender, Type, Service Provider, and Region.

2] Which region is expected to hold the highest share in the Global Blepharoplasty Market?
Ans. The North America region is expected to hold the highest share of the Blepharoplasty Market.

3] What is the market size of the Global Blepharoplasty Market by 2029?
Ans. The market size of the Blepharoplasty Market by 2029 is expected to reach US$ 7.6 Mn.

4] What is the forecast period for the Global Blepharoplasty Market?
Ans. The forecast period for the Blepharoplasty Market is 2021-2029.

5] What was the market size of the Global Blepharoplasty Market in 2022?
Ans. The market size of the BlepharoplastyMarket in 2022 was valued at US$ 4.3 Mn.